Information  X 
Enter a valid email address

GAN PLC (GAN)

  Print   

Friday 13 March, 2020

GAN PLC

Posting of Scheme Circular

RNS Number : 1601G
GAN PLC
13 March 2020
 

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN INVITATION OR OFFER TO SELL OR THE SOLICITATION OF AN INVITATION OR OFFER TO BUY ANY SECURITY. NONE OF THE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT SHALL BE SOLD, ISSUED, SUBSCRIBED FOR, PURCHASED, EXCHANGED OR TRANSFERRED IN ANY JURISDICTION IN CONTRAVENTION OF APPLICABLE LAW

  March, 13 2020

GAN plc

GAN plc ("GAN UK") today announces that it has set the date of its Court Meeting and General Meeting ("Meetings") at which shareholders will be asked to approve the proposed redomiciling of the Company to Bermuda, as previously disclosed on 3 March 2020 ("Scheme").

The Meetings will be held at the offices of Memery Crystal LLP, 165 Fleet Street, London EC4A 2DY on 31 March 2020, starting at 10:00 a.m. (GMT).

In connection with the Meetings, notices of meeting, the Scheme information circular ("Scheme Circular") and proxy materials have been mailed to the shareholders of record as at close of business on 11 March 2020.

The expected timetable of principal events in the redomiciling is set out in the Scheme Circular, and key dates relating to the Meetings will be posted on the Company's website at gan.com.

Prior to the Scheme becoming effective, and subject to applicable requirements of the London Stock Exchange, an application will be made to the London Stock Exchange for the cancellation of the admission of the GAN UK shares to trading on AIM. Further details are included in the Scheme Circular.

The terms and expressions in this news release have the same meaning as given to them in the Scheme Circular, unless the context requires otherwise.

No offer to sell or buy

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended ("Securities Act"). This announcement is being issued in accordance with Rule 135 under the Securities Act.

About GAN UK

GAN UK is a leading business-to-business ("B2B") supplier of internet gambling software-as-a-service solutions ("SaaS") to the US land-based casino industry. GAN UK has developed a proprietary internet gambling enterprise software system, GameSTACK™, which it licenses principally to land-based US casino operators as a turnkey technology solution for regulated real-money internet gambling, encompassing internet gaming, internet sports gaming and virtual Simulated Gaming.

 

For further information please contact:  

 

GAN

US Investors: The Equity Group

Jack Wielebinski

Adam Prior

Head of Investor Relations

[email protected]

+1 214 799 4660

212.371.8660

[email protected]

 

Carolyne Sohn

[email protected]

415.568.2255

 


UK & Ireland Investors: Newgate Communications


Adam Lloyd

Giles Croot


[email protected]


+44 (0) 20 3757 6880

 


Davy (Nominated Adviser and Joint Broker)



John Frain / Barry Murphy



+353 1 679 6363



 

Liberum (Joint Broker)



Neil Patel / Cameron Duncan



+44 (0) 20 3100 2000


 Forward-Looking Statements

This announcement may contain certain forward-looking statements. These forward-looking statements include all matters that are not historical facts. These forward-looking statements involve risks and uncertainties that could cause the actual results of operations, financial condition, prospects and the development of the sector in which GAN UK operates to differ materially from the impression created by these forward-looking statements. GAN UK does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Do not place undue reliance on forward-looking statements, which speak only as of the date of this announcement.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCSFAFMDESSEFD

a d v e r t i s e m e n t